Oxycodone Hydrochloride Tablets, USP C-II, 5 mg, 100 count bottles, Rx Only, Manufactured for: Lu...

FDA Recall #D-0358-2022 — Class III — December 29, 2021

Recall #D-0358-2022 Date: December 29, 2021 Classification: Class III Status: Terminated

Product Description

Oxycodone Hydrochloride Tablets, USP C-II, 5 mg, 100 count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202. Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873. NDC 43386-432-01

Reason for Recall

Out-of-specification impurity test result observed at 18-month long term stability time point.

Recalling Firm

Lupin Pharmaceuticals Inc. — Baltimore, MD

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

23,965 100 count bottles

Distribution

Product Distributed in NY and OH.

Code Information

Lot # S000268, Exp. date January 2022

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated